scispace - formally typeset
S

Sandra Moreno

Researcher at Roma Tre University

Publications -  133
Citations -  10572

Sandra Moreno is an academic researcher from Roma Tre University. The author has contributed to research in topics: Neurodegeneration & Autophagy. The author has an hindex of 34, co-authored 126 publications receiving 8853 citations. Previous affiliations of Sandra Moreno include University of L'Aquila & University of Rome Tor Vergata.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS.

TL;DR: It is suggested that in the adult CNS, PPARs and RXRs, besides playing roles common to many other tissues, may have specific functions in regulating the expression of genes involved in neurotransmission, and therefore play roles in complex processes, such as aging, neurodegeneration, learning and memory.
Journal ArticleDOI

Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease

TL;DR: This work finds a non-apoptotic baseline caspase-3 activity in hippocampal dendritic spines and an enhancement of this activity at the onset of memory decline in the Tg2576-APPswe mouse model of Alzheimer's disease, and identifies a previously unknown casp enzyme-3–dependent mechanism that drives synaptic failure and contributes to cognitive dysfunction in Alzheimer's Disease.
Journal ArticleDOI

'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease.

TL;DR: By crossing Huntington's disease R6/1 transgenic mice with ‘tissue’ transglutaminase (TG2) knock-out mice, it is demonstrated that this multifunctional enzyme plays an important role in the neuronal death characterising this disorder in vivo.